Agentix (AGTX) Interest Coverage Ratio (QoQ) (2017 - 2026)
Agentix (AGTX) Interest Coverage Ratio (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.99% |
| Mar 31, 2026 | 159.27% |
| Dec 31, 2025 | 4.08% |
| Mar 31, 2025 | 169.79% |
| Dec 31, 2024 | 9.28% |
| Sep 30, 2024 | 52.32% |
| Jun 30, 2024 | -712.22% |
| Mar 31, 2024 | 50.51% |
| Dec 31, 2023 | 92.59% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 69.77% |
| Nov 30, 2019 | 57.54% |
| Aug 31, 2019 | 87.26% |
| May 31, 2019 | -68.17% |
| Feb 28, 2019 | 33.81% |
| Nov 30, 2018 | -2,893.89% |
| Aug 31, 2018 | -111.94% |
| May 31, 2018 | -8.76% |
| Feb 28, 2018 | 55.68% |
| Nov 30, 2017 | 111.20% |